Significance of IGFBP-4 in the development of fetal growth restriction

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages

  Qiu, Qing ^a,b   Bell, Mike ^a   Lu, Xiaoyin ^c   Yan, Xiaojuan ^d   Rodger, Marc ^b   Walker, Mark ^a,b   Wen, Shi Wu ^a,b   Bainbridge, Shannon ^b   Wang, Hongmei ^c   Gruslin, Andree ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c INSTITUTE OF ZOOLOGY   (China)

^d HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ADULT; ARTICLE; CASE CONTROL STUDY; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; DECIDUA; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR II; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; TROPHOBLASTS;

ANIMALIA;

EID: 84864815497     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2511     Document Type: Article

References (50)

1. Hack M, Merkatz IR 1995 Preterm delivery and low birth weight: a dire legacy. N Engl J Med 333:1772-1774 (Pubitemid 26007131)
2. Kaufmann P, Black S, Huppertz B 2003 Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1-7 (Pubitemid 36806800)
3. Fowden AL 2003 The insulin-like growth factors and feto-placental growth. Placenta 24:803-812 (Pubitemid 37184807)
4. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82 (Pubitemid 23306022)
5. Han VK, Bassett N, Walton J, Challis JR 1996 The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGFIGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81:2680-2693 (Pubitemid 26240297)
6. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates 3rd JR, Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153 (Pubitemid 29148859)
7. Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I, Imani B, Suen LF, Irwin JC, Christiansen M, Overgaard MT, Oxvig C 2002 Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 87:2359-2366 (Pubitemid 34521531)
8. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Füchtbauer EM, Oxvig C, van Deursen J 2004 Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131:1187-1194 (Pubitemid 38380471)
9. Ning Y, Schuller AG, Conover CA, Pintar JE 2008 Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol Endocrinol 22:1213-1225 (Pubitemid 351629620)
10. Brambati B, Macintosh MC, Teisner B, Maguiness S, Shrimanker K, Lanzani A, Bonacchi I, Tului L, Chard T, Grudzinskas JG 1993Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol 100:324-326 (Pubitemid 23121151)
11. Nicolaides KH 2011 Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 31:7-15
12. Wright D, Spencer K, Kagan KK, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH 2010 First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 36:404-411
13. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME 2004 Firsttrimester maternal serum PAPP-A and free β-subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191:1446-1451 (Pubitemid 39421612)
14. Goetzl L, Krantz D, Simpson JL, Silver RK, Zachary JM, Pergament E, Platt LD, Mahoney MJ, Wapner RJ 2004 Pregnancy-associated plasma protein A, free β-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol 104:30-36 (Pubitemid 40458901)
15. Spencer K, Cowans NJ, Molina F, Kagan KO, Nicolaides KH 2008 First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 31:147-152
16. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM 2002 Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87:1762-1767 (Pubitemid 34615266)
17. Spencer K, Cowans NJ, Avgidou K, Nicolaides KH 2006 First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Ultrasound Obstet Gynecol 28:637-643 (Pubitemid 44619215)
18. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R 2004 Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191:1452-1458 (Pubitemid 39421613)
19. Odibo AO, Zhong Y, Longtine M, Tuuli M, Odibo L, Cahill AG, Macones GA, Nelson DM 2011 First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta 32:333-338
20. Kirkegaard I, Henriksen TB, Uldbjerg N 2011 Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol 37:341-347
21. Odibo AO, Sehdev HM, Stamilio DM, Macones GA 2006 Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. Am J Perinatol 23:363-367 (Pubitemid 44267094)
22. Åsvold BO, Vatten LJ, Romundstad PR, Jenum PA, Karumanchi SA, Eskild A 2011 Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol 173:630-639
23. Qiu Q, Yan X, Bell M, Di J, Tsang BK, Gruslin A 2010 Mature IGF-II prevents the formation of "big" IGF-II/IGFBP-2 complex in the human circulation. Growth Horm IGF Res 20:110-117
24. Qiu Q, Jiang JY, Bell M, Tsang BK, Gruslin A 2007 Activation of endoproteolytic processing of insulin-like growth factor-II in fetal, early postnatal, and pregnant rats and persistence of circulating levels in postnatal life. Endocrinology 148:4803-4811 (Pubitemid 47481519)
25. Walker MC, Finkelstein SA, Rennicks White R, Shachkina S, Smith GN, Wen SW, Rodger M 2011 The Ottawa and Kingston (OaK) Birth Cohort: development and achievements. J Obstet Gynaecol Can 33:1124-1133
26. Wen SW, Fung KF, Huang L, Demissie K, Joseph KS, Allen AC, Kramer MS 2005 Fetal and neonatal mortality among twin gestations in a Canadian population: the effect of intrapair birthweight discordance. Am J Perinatol 22:279-286 (Pubitemid 41096195)
27. Kiyatkin A, Aksamitiene E 2009 Multistrip Western blotting to increase quantitative data output. Methods Mol Biol 536:149-161
28. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK 1993 Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206:204-211 (Pubitemid 23212937)
29. Guibourdenche J, Frendo JL, Pidoux G, Bertin G, Luton D, Muller F, Porquet D, Evain-Brion D 2003 Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta 24:532-539 (Pubitemid 37184775)
30. Roberts L, Sebire NJ, Fowler D, Nicolaides KH 2000 Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta 21:678-683
31. Pidoux G, Gerbaud P, Marpeau O, Guibourdenche J, Ferreira F, Badet J, Evain-Brion D, Frendo JL 2007 Human placental development is impaired by abnormal human chorionic gonadotropin signaling in trisomy 21 pregnancies. Endocrinology 148:5403-5413 (Pubitemid 350012653)
32. Massin N, Frendo JL, Guibourdenche J, Luton D, Giovangrandi Y, Muller F, Vidaud M, Evain-Brion D 2001 Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome. Placenta 22(Suppl A): S93-S97 (Pubitemid 33712466)
33. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L 1993 Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268:12243-12246 (Pubitemid 23182369)
34. Søe R, Overgaard MT, Thomsen AR, Laursen LS, Olsen IM, Sottrup-Jensen L, Haaning J, Giudice LC, Conover CA, Oxvig C 2002 Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity. Eur J Biochem 269:2247-2256 (Pubitemid 34437869)
35. Leung TY, Sahota DS, Chan LW, Law LW, Fung TY, Leung TN, Lau TK 2008 Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol 31:10-14 (Pubitemid 351211924)
36. Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO 2009 The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 201:412-416
37. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH 2000 First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107:1265-1270
38. Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT, Mantingh A 1998 Maternal serum levels of free β-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 18:147-152 (Pubitemid 28077408)
39. Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, Smith GC, Kingdom JC 2009 Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 34:274-282
40. Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A 2007 Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 29:135-140 (Pubitemid 46326584)
41. Montanari L, Alfei A, Albonico G, Moratti R, Arossa A, Beneventi F, Spinillo A 2009 The impact of first-trimester serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant. Fetal Diagn Ther 25:130-135
42. Baker Méio MD, Lopes Moreira ME, Sichieri R, Moura AS 2009 Reduction of IGF-binding protein-3 as a potential marker of intrauterine growth restriction. J Perinat Med 37:689-693
43. Burkhardt T, Matter CM, Lohmann C, Cai H, Lüscher TF, Zisch AH, Beinder E 2009 Decreased umbilical artery compliance and igf-I plasma levels in infants with intrauterine growth restriction: implications for fetal programming of hypertension. Placenta 30:136-141
44. Davidson S, Hod M, Merlob P, Shtaif B 2006 Leptin, insulin, insulin-like growth factors and their binding proteins in cord serum: insight into fetal growth and discordancy. Clin Endocrinol (Oxf) 65:586-592 (Pubitemid 44583817)
45. Bocconi L, Mauro F, Maddalena SE, De Iulio C, Tirelli AS, Pace E, Nicolini U 1998 Insulinlike growth factor 1 in controls and growthretarded fetuses. Fetal Diagn Ther 13:192-196 (Pubitemid 28321287)
46. Hills FA, English J, Chard T 1996 Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 148:303-309 (Pubitemid 26046924)
47. Klauwer D, Blum WF, Hanitsch S, Rascher W, Lee PD, Kiess W 1997 IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns. Acta Paediatr 86:826-833 (Pubitemid 27342725)
48. Gó recki DC, Beresewicz M, Zabłocka B 2007 Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1. Neurochem Int 51:451-458
49. Qiu Q, Basak A, Mbikay M, Tsang BK, Gruslin A 2005 Role of proIGF-II processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci USA 102:11047-11052 (Pubitemid 41105990)
50. Mazerbourg S, Callebaut I, Zapf J, Mohan S, Overgaard M, Monget P 2004 Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo. Growth Horm IGF Res 14:71-84 (Pubitemid 38332072)